Progressive Announces Dividend Information And 2025 Annual Meeting Record DateProgressive Announces Dividend Information And 2025 Annual Meeting Record Date GlobeNewswire
||
MAYFIELD VILLAGE, OHIO, Dec. 09, 2024 (GLOBE NEWSWIRE) — On December 6, 2024, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared an annual common share dividend, in... 
Riverside Natural Foods Ltd. Issues Voluntary Recall of Select MadeGood Granola Bar Products Over Potential Presence of a Piece of MetalRiverside Natural Foods Ltd. Issues Voluntary Recall of Select MadeGood Granola Bar Products Over Potential Presence of a Piece of Metal GlobeNewswire
||
Proactive Measures Taken to Ensure Consumer Safety; No Injuries Reported TORONTO, Dec. 09, 2024 (GLOBE NEWSWIRE) — Riverside Natural Foods Ltd. is voluntarily recalling certain batches of MadeGood granola... 
Riverside Natural Foods Inc. Issues Voluntary Recall of Select MadeGood Granola Bar Products Over Potential Presence of a Piece of MetalRiverside Natural Foods Inc. Issues Voluntary Recall of Select MadeGood Granola Bar Products Over Potential Presence of a Piece of Metal GlobeNewswire
||
Proactive Measures Taken to Ensure Consumer Safety; No Injuries Reported Media Contact: madegood@webershandwick.comConsumer Hotline: 855-215-5695 CHICAGO, Dec. 09, 2024 (GLOBE NEWSWIRE) — Riverside Natural Foods Inc. is voluntarily recalling... 
Second Circuit Revives NCLA’s Lawsuit Against Ethics Rule Muzzling Connecticut Attorneys’ SpeechSecond Circuit Revives NCLA’s Lawsuit Against Ethics Rule Muzzling Connecticut Attorneys’ Speech GlobeNewswire
||
Mario Cerame and Timothy Moynahan v. Christopher L. Slack, in his official capacity as Connecticut Statewide Bar Counsel, and Matthew G. Berger, in his official capacity as Chair of... 
Organic & Natural Health Association’s 10th Annual Conference Explores Sustainability From an International PerspectiveOrganic & Natural Health Association’s 10th Annual Conference Explores Sustainability From an International Perspective GlobeNewswire
||
FT. LAUDERDALE, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) — The Organic & Natural Health Association (Organic & Natural Health) will host its 10th annual conference at B Ocean Resort... 
Nokia Corporation: Repurchase of own shares on 09.12.2024Nokia Corporation: Repurchase of own shares on 09.12.2024 GlobeNewswire
||
Nokia Corporation Stock Exchange Release 9 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 09.12.2024 Espoo, Finland – On 9 December 2024 Nokia Corporation (LEI:... 
VivoPower’s Caret Digital secures asset backed financing facility for up to 1,000 Antminer L9s to accelerate DOGE coin mining revenues and free cashflowsVivoPower’s Caret Digital secures asset backed financing facility for up to 1,000 Antminer L9s to accelerate DOGE coin mining revenues and free cashflows GlobeNewswire
||
Asset backed financing facility is for Caret LLC (trading as Caret Digital) and is non-dilutive to VivoPower shareholders At current DOGE coin prices, 1,000 Antminer L9s can generate up... 
Statement from the National Association of Federal Retirees on Pension SurplusStatement from the National Association of Federal Retirees on Pension Surplus GlobeNewswire
||
OTTAWA, Ontario, Dec. 09, 2024 (GLOBE NEWSWIRE) — The National Association of Federal Retirees is concerned about the federal government’s handling of non-permitted surplus funds, which has resulted in... 
Vow ASA: Preliminary results of the rights issueVow ASA: Preliminary results of the rights issue GlobeNewswire
||
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA OR... 
Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) GlobeNewswire
||
AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at the highest dose level (300 mg) in heavily...